GB2325408B - Chewing gum formulation comprising ondansetron - Google Patents
Chewing gum formulation comprising ondansetronInfo
- Publication number
- GB2325408B GB2325408B GB9816045A GB9816045A GB2325408B GB 2325408 B GB2325408 B GB 2325408B GB 9816045 A GB9816045 A GB 9816045A GB 9816045 A GB9816045 A GB 9816045A GB 2325408 B GB2325408 B GB 2325408B
- Authority
- GB
- United Kingdom
- Prior art keywords
- ondansetron
- chewing gum
- gum formulation
- formulation
- chewing
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Classifications
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
- B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/69—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit
- A61K47/6949—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes
- A61K47/6951—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the conjugate being characterised by physical or galenical forms, e.g. emulsion, particle, inclusion complex, stent or kit inclusion complexes, e.g. clathrates, cavitates or fullerenes using cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
- A61K9/0058—Chewing gums
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nanotechnology (AREA)
- Zoology (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Nutrition Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9816045A GB2325408B (en) | 1994-06-28 | 1994-06-28 | Chewing gum formulation comprising ondansetron |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9412950A GB2290963A (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical uses of ondansetron |
GB9816045A GB2325408B (en) | 1994-06-28 | 1994-06-28 | Chewing gum formulation comprising ondansetron |
Publications (3)
Publication Number | Publication Date |
---|---|
GB9816045D0 GB9816045D0 (en) | 1998-09-23 |
GB2325408A GB2325408A (en) | 1998-11-25 |
GB2325408B true GB2325408B (en) | 1999-01-27 |
Family
ID=10757437
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9412950A Withdrawn GB2290963A (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical uses of ondansetron |
GB9816045A Expired - Fee Related GB2325408B (en) | 1994-06-28 | 1994-06-28 | Chewing gum formulation comprising ondansetron |
GB9822734A Withdrawn GB2327348A (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical use of ondansetron |
GB9816046A Expired - Fee Related GB2325409B (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical use of ondansetron/cyclodextrin complexes |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9412950A Withdrawn GB2290963A (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical uses of ondansetron |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB9822734A Withdrawn GB2327348A (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical use of ondansetron |
GB9816046A Expired - Fee Related GB2325409B (en) | 1994-06-28 | 1994-06-28 | Pharmaceutical use of ondansetron/cyclodextrin complexes |
Country Status (1)
Country | Link |
---|---|
GB (4) | GB2290963A (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20080213363A1 (en) * | 2003-01-23 | 2008-09-04 | Singh Nikhilesh N | Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa |
DE102010024050B4 (en) | 2010-06-16 | 2014-12-31 | Magna Car Top Systems Gmbh | Moving roof for a passenger car |
CN103919052A (en) * | 2014-01-21 | 2014-07-16 | 中国人民解放军第三军医大学 | Composition used for physical recovery, and its application |
WO2018129434A1 (en) | 2017-01-09 | 2018-07-12 | Gt Biopharma, Inc. | Use and composition for treating myasthenia gravis and other myasthenic syndromes |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2153821A (en) * | 1984-01-25 | 1985-08-29 | Glaxo Group Ltd | 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE3688296T2 (en) * | 1985-03-14 | 1993-11-04 | Beecham Group Plc | MEDICINES FOR TREATING EMERGENCY. |
US5288497A (en) * | 1985-05-01 | 1994-02-22 | The University Of Utah | Compositions of oral dissolvable medicaments |
US5166145A (en) * | 1990-09-10 | 1992-11-24 | Alza Corporation | Antiemetic therapy |
-
1994
- 1994-06-28 GB GB9412950A patent/GB2290963A/en not_active Withdrawn
- 1994-06-28 GB GB9816045A patent/GB2325408B/en not_active Expired - Fee Related
- 1994-06-28 GB GB9822734A patent/GB2327348A/en not_active Withdrawn
- 1994-06-28 GB GB9816046A patent/GB2325409B/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2153821A (en) * | 1984-01-25 | 1985-08-29 | Glaxo Group Ltd | 3-Imidazolylmethyl-1,2,3,9-tetrahydro-4H-carbazol-4-one derivatives |
Also Published As
Publication number | Publication date |
---|---|
GB2325409A (en) | 1998-11-25 |
GB2325408A (en) | 1998-11-25 |
GB9822734D0 (en) | 1998-12-16 |
GB9816046D0 (en) | 1998-09-23 |
GB2325409B (en) | 1999-02-10 |
GB2327348A (en) | 1999-01-27 |
GB2290963A (en) | 1996-01-17 |
GB9412950D0 (en) | 1994-10-26 |
GB9816045D0 (en) | 1998-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GR3033556T3 (en) | Non-stick chewing gum | |
EG24077A (en) | Oral 2-methyl-thieno-benzodiazepine formulation | |
PL319604A1 (en) | Fruit-juice filled chewing gum | |
FI954867A (en) | Chewing gum | |
AU5510398A (en) | Crunchy chewing gum | |
PL333101A1 (en) | Chewing gum containing colloidal basic bismuth citrate | |
HUP0002216A2 (en) | Oral compositions | |
EP0725567A4 (en) | Improved chewing gum compositions and methods for manufacturing same | |
AU8055394A (en) | Chewing gum | |
NZ300435A (en) | Oral compositions comprising an aminoalkylsilicone | |
EP0472428A3 (en) | Low moisture chewing gum | |
ZA955519B (en) | Oral compositions | |
PL320866A1 (en) | Oral compositions | |
EP0758850A4 (en) | Improved sugarless non-tack chewing gum | |
EP0907325A4 (en) | Chewing gum containing gum talha | |
EP0793421A4 (en) | Improved chewing gum containing salatrim | |
GB2325408B (en) | Chewing gum formulation comprising ondansetron | |
PL320865A1 (en) | Oral compositions | |
EP1032276A4 (en) | Chewing gum containing trehalose | |
EP0575977A3 (en) | Chewing gum compositions. | |
AU1086495A (en) | Improved chewing gum containing caprenin | |
GB9907207D0 (en) | Tooth 'n' gum chewing gum | |
GB9700412D0 (en) | Chewing gum | |
GB9513690D0 (en) | Chewing gum | |
GB2292886B (en) | Oral hygiene formulation |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
732E | Amendments to the register in respect of changes of name or changes affecting rights (sect. 32/1977) | ||
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 20000628 |